Larry Schnurmacher is a career investment professional having managed capital for high net worth individuals for over 25 years. After retiring from Morgan Stanley in 2015, Mr. Schnurmacher founded Phyto Partners to help investors capitalize on the opportunity in the Cannabis industry. Over the past 5 years, Mr. Schnurmacher has invested in 25 privately held cannabis companies, building Phyto Partners into one of the preeminent venture capital private equity funds in the space being recognized as a Top Cannabis Investment fund by Forbes and BusinessInsider. M
Evan has held several positions creating content and executing digital marketing strategies at Information Television and The Birds Nest Foundation. For the past two years Evan has held sales and client delivery roles at Yext. Evan graduated University of Maryland with a BA.
Jonathan has worked as an analyst at Comvest Partners, where he was responsible for identifying, originating, and qualifying new investment opportunities. Jonathan graduated with a degree in Finance from the University of Florida.
David is a partner at Presidential Services handling concierge travel for executives and corporations. David has also been a licensed real estate agent at Douglas Elliman. David graduated University of Indiana with a BA.
Mr. Harvey Sandler is the Founder and the retired Managing Director at Sandler Capital Management, a public and private equity investment fund which managed in excess of $1 billion. Prior to this, Mr. Sandler joined Goldman Sachs and Co. where he served as Vice President in the Communications Industries Group from 1970 to 1979. He has a vast experience investing in the communications and media industries. Mr. Sandler is an active philanthropist involved with many organizations including Jewish Federation. Harvey serves as Trustee of Boca Raton Regional Hospital a role which he has become very passionate about. Mr. Sandler graduated from Columbia Business School in 1966. Mr. Sandler is a 20 plus year brain cancer survivor and an advocate for brain cancer research.
CHARLES A. (CHUCK) LIEPPE
Charles A. (Chuck) Lieppe is an experienced C-suite executive in a variety of industries, including health care. As a corporate V.P. at Procter & Gamble, Mr. Lieppe established P&G in the pharmaceutical and OTC drug businesses through internal product development and orchestrating multi-national acquisitions for the Health & Personal Care Division. Chuck held positions of COO at Westpoint Pepperell, CEO of Nabisco International, CEO Berol Corporation and CEO DBT Online. Mr. Lieppe graduated from Columbia University with an AB in English and an MBA in Marketing and Finance. Mr. Lieppe is a private investor who advises and sits on boards of private equity companies.
GARY RUBIN, CPA
Gary Rubin is the Managing Member and co-founder of Masters Research Partners, LLC a fund of funds. Mr. Rubin has been responsible for manager selection and due diligence since the fund’s inception in 2000. Mr. Rubin as also a CPA and began his career with Deloitte and Touche. Mr. Rubin has been involved in the investment business, including hedge funds, private equity and investment banking for over 25 years. Prior to moving to Florida, Mr. Rubin was a Managing Partner at Schissel, Rubin and Lehman, a New York based Certified Public Accounting firm. Mr. Rubin graduated with a Bachelor of Science cum laude from SUNY at Buffalo in 1977.
Mr. Foster has worked with some of the world’s largest retailers and financial institutions to define, design and implement e-commerce and retail payment processing and risk management solutions. Between 1998 and 2012 Mr. Foster founded or co-founded 4 successful companies in the financial services space. Paymentplus, Inc., Payventures, Cardplatforms and Payteller. In 2014 Mr. Foster and his co-founder created JaneFour20, a subsidiary of Payteller, in order to respond to overwhelming requests for cash management and financial services solutions in the legal cannabis industry.
Seth Hyman is the Business Development/Special Projects Director for the law firm Kelley Kronenberg and an integral member of the Regulated Substances practice group. Seth’s understanding and support of the campaign to legalize medical cannabis is rooted in his personal experiences. His daughter Rebecca, has a severe genetic disorder which causes her to have frequent daily seizures. Oil extracted from a non-euphoric strain of cannabis has been shown to treat children with his daughter’s condition of intractable epilepsy. Over the past 4 years, Seth has become one of the most visible faces in Florida’s burgeoning medical cannabis industry. He has been instrumental in lobbying for the Florida legislation to help his daughter and others thwart seizures and comfort those with epilepsy. Seth was a key figure throughout the lawmaking process for both House Bill 843 and Senate Bill 1030 in the 2014 Florida legislative session. He worked closely with legislators by providing input on the drafting of language for both bills and delivered powerful testimonies to the governmental committees. Seth has advocated for the state’s Compassionate Medical Cannabis Act in legislative and other public forums, and retains deep relationships with key decisions makers in federal and state government.
Brett is an experienced executive, venture capital and private equity investor and advisor. He has partnered with and developed key relationships with numerous premier private equity firms, investment banks, and venture capital funds. As a transactional entrepreneur and a relationship focused advisor, he has been involved in founding, funding, and operational roles at both startups and established companies. Brett has significant experience working with private and public companies, where he brings extensive knowledge and leadership skills to in every facet of the organization. Brett has 20 years of investment banking performance and has been involved in close to a billion dollars of transactions involving a wide variety of mergers and acquisitions, debt and equity financing, turnarounds, licensing, branding and investor relations for many prestigious corporations, and private equity firms. During his career he has been involved in and has focused his professional journey on driving profitability and shareholder returns. Brett has also served on or been an advisor to numerous boards of directors of companies, private equity firms, and advisory organizations. Brett has been involved in providing business strategy and is greatly experienced with developing and implementing business growth strategies.
LEGAL COUNSEL – ADAM GREENE
Adam Greene is a Partner in the firm’s Corporate Transactional, Capital Markets and Business Finance & Restructuring Departments. Adam regularly represents buyers, sellers, companies, and investors in strategic and financial mergers and acquisitions, private equity financings, recapitalizations, and restructurings. Adam also advises early and growth stage companies and investors in venture and growth capital financings and serves as outside general counsel to emerging growth and established operating companies. Adam’s practice also includes representing parties in interest in bankruptcy proceedings, including debtors, secured lenders, unsecured creditors, creditors’ committees, trustees, asset purchasers from distressed companies, investors in distressed debt, out-of-court restructuring, and lending institutions providing debtor-in-possession financing.
FUND ADMINISTRATOR – SAM CRISPINO
NAV has provided comprehensive, independent Fund Administration, reporting and analytics, investor services, and back office support to the hedge fund industry for over 25 years now. NAV’s fund administration technology is proprietary and wholly-owned, giving it both flexibility in reporting and confidentiality that our client’s demand. NAV is not affiliated with any bank, broker, or other services provider. Being 100% privately owned for our entire history has meant one thing above all: we are not bound by the need for short-term investor results. We have always been free to make our priority a long-term view with continuous investments into our infrastructure, our people, and our technology. NAV’s wholly-owned, proprietary technology, also eliminates any dependence on licensing technology from competitors or other third parties.